Impact of COVID-19 Lockdown on Depression Severity and the Use of Drugs Among University of Ibadan Students

Authors

  • Abdulhammed Opeyemi Babatunde Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan; Healthy Africans Platform, Ibadan, Nigeria
  • Lordstrong Akano Olaniyi Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • AbdulSobur Olatunde Abdulazeez Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Yeshua Ayokun Adedeji Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Boluwatife Adefunke Bolatito Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Christabel Ijeoma Uche-Orji Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Adeniyi Abraham Adesola Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Habib Ayomide Shobanke Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Dimeji AbdulSobur Olawuyi Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
  • Dolapo Michael Babalola Department of Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria

DOI:

https://doi.org/10.5195/ijms.2021.837

Keywords:

depression, COVID-19, Drug abuse, students, mental health

Abstract

Background: Since the declaration of COVID-19 as a pandemic, measures such as nationwide lockdowns have been implemented. The sudden disruption of activities coupled with fear could trigger or aggravate mental illnesses and consequently, increase substance use as a coping mechanism. This study then sought to assess the impact of the lockdown on depression and substance use amongst students in a tertiary institution in Ibadan city, Nigeria.

Methods: A self-administered 26 questions online questionnaire was employed for data collection of socio-demographic characteristics, Patient Health Questionnaire (PHQ-9) to assess depression, and a section on the use of psychoactive drugs during lockdown. Data were statistically analyzed using IBM's SPSS and Microsoft Excel.

Results: We gathered 102 responses, 54.9% were males. Most of the respondents had mild depression (41.2%), followed by 36.3% that reported not having an episode of depression, 15.7% moderate, 4.9% moderately severe, and 2% severe depression. Female had more depressive episodes than males (p=0.185). Only 4% reported substance use since the pandemic, all were male. At a 95% confidence interval, there was no significant association between the level of depression and any socio-demographic characteristics of students and between the level of depression and drug use.

Conclusions: According to this study, lockdown and other mitigation strategies implemented during the pandemic were not found to be associated with drug use. A limitation of this study is the cross-sectional design, as a result, a larger multicenter study is needed to ascertain the possible association between lockdown, depressive symptoms, and drug use among students.

References

Wang Y, Grunewald M, Perlman S. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis. Methods Mol Biol. 2020;2203:1-29.

Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020 Jul 6;16(1):57.

World Health Organization. Regional Office for Europe. WHO announces COVID-19 outbreak a pandemic. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic. Last updated Mar 12, 2020; cited Sep 9, 2020.

Zhang Y, Ma ZF. Impact of COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province China: a cross sectional study. Int J Environ Res Public Health. 2020 Mar 31;17(7):2381.

Mazza C, Ricci E, Biondi S, Colasanti M, Ferracuti S, Napoli C, et al. A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors. Int J Environ Res Public Health. 2020 May 2;17(9):3165.

Holmes EA, O’Connor RC, Perry VH Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020 Jun;7(6): 547-60.

Ethman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S . Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020 Sep 1;3(9):e2019686

Alharbi R, Alsuhaibani K, Almarshad A, Alyahya A. Depression and anxiety among high school students at Qassim region. J Family Prim Care. 2019 Feb;8(2):504-10.

Gulf Bend Center. Substance/Medication-Induced Depressive disorder. Available from: https://www.gulfbend.org/poc/view_doc.php?type=doc&id=12981&en=. Last updated 2008; cited Sep 20, 2020.

Smith K. PSYCOM. Substance abuse and Depression. Available from: https://www.psycom.net/depression-substance-abuse. Last updated November 2018; cited Sept 20, 2020.

Wright K, Sarangi A, Ibrahim Y. The psychiatric effects of COVID-19 thus far: a review of the current literature. The Chronicles. 2020Jul.23;8(35):17-8.

Sarangi A, Mcmahon T, Gude J. Benzodiazepine Misuse: An Epidemic Within a Pandemic. Cureus. 2021;13(6): e15816.

Sarangi A, Eskander N. The Worsening Outcomes of the COVID-19 Lockdowns on Patients with a History of Alcoholism, Alcoholism Treatment Quarterly. 2021;39:3, 342-347

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.

Cameron IM, Crawford JR, Lawton K, Reid IC. Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract. 2008 Jan;58(546):32-6.

Islam MA, Barna SD, Raihan H, Khan MNA, Hossain MT. Depression and anxiety among university students during the COVID-19 pandemic in Bangladesh: A web-based cross-sectional survey. PLoS One. 2020 Aug 26;15(8):e0238162.

Lara E, Caballero FF, Rico-Uribe LA, Olaya B, Haro JM, Ayuso-Mateos JL, et al. Are loneliness and social isolation associated with cognitive decline? Int J Geriatr Psychiatry. 2019 Nov;34(11):1613-22.

Altena E, Baglioni C, Espie CA, Ellis J, Gavriloff D, Holzinger B, et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J Sleep Res. 2020 Aug;29(4):e13052.

Li Y, Qin Q, Sun Q, Vgontzas AN, Tang X. Insomnia and psychological reactions during the COVID-19 outbreak in China. J. Clin. Sleep Med. 2020 Aug 15;16(8):1417-18.

Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020 Jun;288:112954.

Solomou I, Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int. J. Environ. Res. Public Health. 2020 Jul 8;17(14):4924.

McCullough ME, Larson DB. Religion and depression: a review of the literature. Twin Res. 1999 Jun;2(2):126–36.

Vasegh S, Mohammadi MR. Religiosity, anxiety, and depression among a sample of iranian medical students. Int. J. Psychiatry Med. 2007 Jan;37(2):213–27.

Gureje O, Lasebikan VO, Ephraim-Oluwanuga O, et al. Community study of knowledge of and attitude to mental illness in Nigeria. Br J Psychiatry. 2005 May;186:436–41.

Meo SA, Abukhalaf AA, Alomar AA, Sattar K, Klonoff DC. COVID-19 Pandemic: Impact of Quarantine on Medical Students' Mental Wellbeing and Learning Behaviors. Pak J Med Sci. 2020 May;36(COVID19-S4):S43-S48.

Blasi MD, Giardina A, Giordano C, Coco GL, Tosto C, Billieux J, et al. Problematic video game use as an emotional coping strategy: Evidence from a sample of MMORPG gamers. J Behav Addict. 2019 Mar 1;8(1):25-34.

Jacobs DF. A general theory of addictions: A new theoretical model. J Gambling Stud. 1986 Mar;2:15–31.

Khantzian EJ. Addiction as a self-regulation disorder and the role of self-medication. Addiction. 2013 Apr;108(4):668-9.

Király O, Urbán R, Griffiths MD, Ágoston C, Nagygyörgy K, Kökönyei G, et al. The mediating effect of gaming motivation between psychiatric symptoms and problematic online gaming: an online survey. J Med Internet Res. 2015 Apr 7;17(4):e88.

King DL, Delfabbro PH, Billieux J, Potenza MN. Problematic online gaming and the COVID-19 pandemic. J Behav Addict. 2020 Apr 29;9(2):184-6.

Ko C.H., Yen J.-Y. 2020. Impact of COVID-19 on gaming disorder: monitoring and prevention. J Behav Addict. 2020 Jun 6;9(2):187-9.

Mestre-Bach G, Blycker G, Potenza M. Pornography use in the setting of the COVID-19 pandemic. J Behav Addict. 2020 Jun;9(2):181-3.

Abrahao KP, Salinas AG, Lovinger DM. Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. Neuron.2017 Dec 20;96(6):1223-38.

Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997 Jan-Feb;4(5):231-44.

Zato?ski WA, Wojty?a A. From the editors. J Health Inequal. 2019 Dec 30;5(2):121.

Chodkiewicz J, Talarowska M, Miniszewska J, Nawrocka N, Bilinski P. Alcohol Consumption Reported during the COVID-19 Pandemic: The Initial Stage. Int J Environ Res Public Health. 2020 Jun 29;17(13):4677.

Rudenstine S, McNeal K, Schulder T, Ettman CK, Hernandez M, Gvozdieva K, et al. Depression and Anxiety During the COVID-19 Pandemic in an Urban, Low-Income Public University Sample. J Trauma Stress. 2020 Oct 12; 34(1):12-22.

Downloads

Published

2021-12-16 — Updated on 2022-01-06

Versions

How to Cite

Babatunde, A. O., Olaniyi, L. A. ., Abdulazeez, A. O. ., Adedeji, Y. A. ., Bolatito, B. A. ., Uche-Orji, C. I. ., Adesola, A. A. ., Shobanke, . H. A., Olawuyi, D. A. ., & Babalola, D. M. . (2022). Impact of COVID-19 Lockdown on Depression Severity and the Use of Drugs Among University of Ibadan Students. International Journal of Medical Students, 9(4), 264–268. https://doi.org/10.5195/ijms.2021.837 (Original work published December 16, 2021)

Issue

Vol. 9 No. 4 (2021)

Section

Original Article

Categories

License

Copyright (c) 2020 Abdulhammed Opeyemi Babatunde, Dimeji AbdulSobur Olawuyi, Habib Ayomide Shobanke, Adeniyi Abraham Adesola, Christabel Ijeoma Uche-Orji, Boluwatife Adefunke Bolatito, Yeshua Ayokun Adedeji, AbdulSobur Olatunde Abdulazeez, Lordstrong Akano Olaniyi, Dolapo Michael Babalola

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org

Similar Articles

You may also start an advanced similarity search for this article.